Prospective Randomized Blinded Trial of VersaWrap Tendon Protector for Zone 2 Flexor Tendon Injuries

ConditionFlexor Tendon
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-99
SponsorUniversity of Florida

About this trial

To analyze outcomes between patients with Z2FT injuries following repair, randomized to two groups. The first group will be the negative control, with no tendon wrap. The second group will have a VersaWrap Tendon Protector applied over the site of the tendon repair. VersaWrap is current SOC at UF.

Eligibility criteria

Qualifiers

Adult patients presenting to the plastic surgery service with a zone 2 flexor tendon injury requiring surgical repair

Disqualifiers

Patients with a sensitivity or allergy to polysaccharides alginate, hyaluronic acid, or citrate

Patients with psychiatric or medical problems that preclude them from having surgery

Female patients that are pregnant or breastfeeding

Prisoners

Trial design

Treatments tested in this trial

  • Standard of Care Surgical Procedure
  • VersaWrap Treatment

Treatment groups

42 Participants
are divided into 2 treatment groups

Sponsors and collaborators